These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 19909080

  • 1. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
    Xie H, Liu TM, Lu X, Wu Z, Belser JA, Katz JM, Tumpey TM, Ye Z.
    J Infect Dis; 2009 Dec 15; 200(12):1874-83. PubMed ID: 19909080
    [Abstract] [Full Text] [Related]

  • 2. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z, Chen Q, Wu R, Zhang H, Zheng M, Wang H, Chen Z.
    Arch Virol; 2010 Apr 15; 155(4):535-44. PubMed ID: 20195654
    [Abstract] [Full Text] [Related]

  • 3. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
    Price GE, Soboleski MR, Lo CY, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL.
    Vaccine; 2009 Nov 05; 27(47):6512-21. PubMed ID: 19729082
    [Abstract] [Full Text] [Related]

  • 4. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
    Kreijtz JH, Bodewes R, van den Brand JM, de Mutsert G, Baas C, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.
    Vaccine; 2009 Aug 06; 27(36):4983-9. PubMed ID: 19538996
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z, Chen Q, Fang F, Zheng M, Chen Z.
    Vaccine; 2010 Nov 10; 28(48):7690-8. PubMed ID: 20870054
    [Abstract] [Full Text] [Related]

  • 7. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 10; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 8. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
    Seo SU, Lee KH, Byun YH, Kweon MN, Seong BL.
    Vaccine; 2007 Nov 19; 25(47):8067-76. PubMed ID: 17919786
    [Abstract] [Full Text] [Related]

  • 9. Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
    Thueng-in K, Maneewatch S, Srimanote P, Songserm T, Tapchaisri P, Sookrung N, Tongtawe P, Channarong S, Chaicumpa W.
    Vaccine; 2010 Sep 24; 28(41):6765-77. PubMed ID: 20688037
    [Abstract] [Full Text] [Related]

  • 10. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.
    Lu X, Edwards LE, Desheva JA, Nguyen DC, Rekstin A, Stephenson I, Szretter K, Cox NJ, Rudenko LG, Klimov A, Katz JM.
    Vaccine; 2006 Nov 10; 24(44-46):6588-93. PubMed ID: 17030078
    [Abstract] [Full Text] [Related]

  • 11. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K, Braeckmans D, Cox E, Van Borm S, van den Berg T, Goddeeris B, De Vleeschauwer A.
    Vaccine; 2009 Oct 23; 27(45):6330-9. PubMed ID: 19840669
    [Abstract] [Full Text] [Related]

  • 12. Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.
    Furuya Y, Regner M, Lobigs M, Koskinen A, Müllbacher A, Alsharifi M.
    J Gen Virol; 2010 Jun 23; 91(Pt 6):1450-60. PubMed ID: 20147516
    [Abstract] [Full Text] [Related]

  • 13. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.
    Vaccine; 2006 Nov 17; 24(47-48):6859-66. PubMed ID: 17050041
    [Abstract] [Full Text] [Related]

  • 14. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.
    Holman DH, Wang D, Raja NU, Luo M, Moore KM, Woraratanadharm J, Mytle N, Dong JY.
    Vaccine; 2008 May 19; 26(21):2627-39. PubMed ID: 18395306
    [Abstract] [Full Text] [Related]

  • 15. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.
    Ernst WA, Kim HJ, Tumpey TM, Jansen AD, Tai W, Cramer DV, Adler-Moore JP, Fujii G.
    Vaccine; 2006 Jun 12; 24(24):5158-68. PubMed ID: 16713037
    [Abstract] [Full Text] [Related]

  • 16. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
    Harada Y, Ninomiya-Mori A, Takahashi Y, Shirakura M, Kishida N, Kageyama T, Tada Y, Tashiro M, Odagiri T.
    Vaccine; 2011 Oct 26; 29(46):8330-7. PubMed ID: 21911027
    [Abstract] [Full Text] [Related]

  • 17. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.
    Vaccine; 2008 Jun 02; 26(23):2912-8. PubMed ID: 18448208
    [Abstract] [Full Text] [Related]

  • 18. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P.
    Vaccine; 2017 Jul 24; 35(33):4177-4183. PubMed ID: 28668565
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.
    Wu J, Zhang F, Fang F, Chang H, Wang F, Yang Z, Sun B, Chen Z.
    Vaccine; 2010 Mar 24; 28(15):2775-81. PubMed ID: 20117261
    [Abstract] [Full Text] [Related]

  • 20. Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination.
    Hwang SD, Shin JS, Ku KB, Kim HS, Cho SW, Seo SH.
    Vaccine; 2010 Apr 09; 28(17):2957-64. PubMed ID: 20188684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.